{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:01:00Z","timestamp":1760061660774,"version":"3.44.0"},"reference-count":16,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2025.12947","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T11:26:51Z","timestamp":1755084411000},"page":"1-5","source":"Crossref","is-referenced-by-count":1,"title":["Efgartigimod for immune checkpoint inhibitor induced polyradiculoneuropathy and cardiomyopathy: A case report"],"prefix":"10.3892","volume":"30","author":[{"given":"Siqi","family":"Dong","sequence":"first","affiliation":[{"name":"Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangyang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihong","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"author":"Larroquette","key":"key20250911085109_b1-ETM-30-4-12947"},{"issue":"98","key":"key20250911085109_b2-ETM-30-4-12947","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-021-01530-2","article-title":"Mechanisms driving immune-related adverse events in cancer patients treated with immune checkpoint inhibitors","volume":"23","author":"Lee","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"key20250911085109_b3-ETM-30-4-12947","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S1474-4422(23)00369-1","article-title":"Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes","volume":"23","author":"Farina","year":"2024","journal-title":"Lancet Neurol"},{"key":"key20250911085109_b4-ETM-30-4-12947","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/onco.13931","article-title":"Immune checkpoint inhibitor induced myocarditis with myositis\/myasthenia gravis overlap syndrome: A systematic review of cases","volume":"26","author":"Pathak","year":"2021","journal-title":"Oncologist"},{"issue":"21","key":"key20250911085109_b5-ETM-30-4-12947","doi-asserted-by":"publisher","DOI":"10.1186\/s40959-020-00076-6","article-title":"Severe combined cardiac and neuromuscular toxicity from immune checkpoint blockade: An institutional case series","volume":"6","author":"Arora","year":"2020","journal-title":"Cardiooncology"},{"key":"key20250911085109_b6-ETM-30-4-12947","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/HCO.0000000000000622","article-title":"Immune checkpoint inhibitor myocarditis","volume":"34","author":"Raikhelkar","year":"2019","journal-title":"Curr Opin Cardiol"},{"key":"key20250911085109_b7-ETM-30-4-12947","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1172\/JCI97911","article-title":"Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans","volume":"128","author":"Ulrichts","year":"2018","journal-title":"J Clin Invest"},{"issue":"S2319","key":"key20250911085109_b8-ETM-30-4-12947","article-title":"Efgartigimod for pembrolizumab-induced myasthenia gravis refractory to standard therapy (P1-8.006)","volume":"100 (Suppl 17)","author":"Campbell","year":"2023","journal-title":"Neurology"},{"issue":"266","key":"key20250911085109_b9-ETM-30-4-12947","article-title":"Aids to the investigation of peripheral nerve injuries","volume":"122","year":"1943","journal-title":"JAMA"},{"key":"key20250911085109_b10-ETM-30-4-12947","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","article-title":"Studies of illness in the aged. The index of adl: A standardized measure of biological and psychosocial function","volume":"185","author":"Katz","year":"1963","journal-title":"JAMA"},{"key":"key20250911085109_b11-ETM-30-4-12947","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/mus.10045","article-title":"Psychometric evaluation of a new handicap scale in immune-mediated polyneuropathies","volume":"25","author":"Merkies","year":"2002","journal-title":"Muscle Nerve"},{"issue":"812","key":"key20250911085109_b12-ETM-30-4-12947","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-022-05767-y","article-title":"Effect of hyaluronic acid on cytokines and immune cells change in patients of knee osteoarthritis","volume":"23","author":"Jin","year":"2022","journal-title":"BMC Musculoskelet Disord"},{"key":"key20250911085109_b13-ETM-30-4-12947","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s00415-020-10213-x","article-title":"Polyradiculoneuropathy induced by immune checkpoint inhibitors: A case series and review of the literature","volume":"268","author":"Okada","year":"2021","journal-title":"J Neurol"},{"key":"key20250911085109_b14-ETM-30-4-12947","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1080\/14712598.2021.1897101","article-title":"A systematic review of immune checkpoint inhibitor-related neurological adverse events and association with anti-neuronal autoantibodies","volume":"21","author":"Salim","year":"2021","journal-title":"Expert Opin Biol Ther"},{"key":"key20250911085109_b15-ETM-30-4-12947","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00262-021-03053-9","article-title":"Neurological disorders associated with immune checkpoint inhibitors: An association with autoantibodies","volume":"71","author":"Seki","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"key20250911085109_b16-ETM-30-4-12947","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1161\/CIRCRESAHA.124.323816","article-title":"Autoimmune myocarditis, old dogs and new tricks","volume":"134","author":"Won","year":"2024","journal-title":"Circ Res"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:51:18Z","timestamp":1757569878000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2025.12947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":16,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8,13]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2025.12947","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"type":"print","value":"1792-0981"},{"type":"electronic","value":"1792-1015"}],"subject":[],"published":{"date-parts":[[2025,8,13]]}}}